Health Care & Life Sciences » Biotechnology | Amarantus BioScience Holdings Inc.

Amarantus BioScience Holdings Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
70.00
153.00
176.00
58.90
17.20
-
Gross Income
70.00
153.00
176.00
58.90
17.20
-
SG&A Expense
5,641.10
21,201.00
24,645.00
8,560.00
3,197.50
2,838.80
EBIT
5,711.10
21,354.00
24,821.00
8,619.00
3,214.70
2,838.80
Unusual Expense
6,789.60
5,060.00
1,835.00
1,190.30
-
-
Non Operating Income/Expense
-
50.00
-
134.60
1.80
-
Interest Expense
2,630.90
813.00
2,228.00
4,055.90
1,266.80
955.60
Pretax Income
15,131.70
27,277.00
25,214.00
11,582.90
4,437.60
10,382.90
Consolidated Net Income
15,131.70
27,277.00
25,214.00
11,582.90
4,437.60
10,382.90
Net Income
15,131.70
27,277.00
25,214.00
11,582.90
4,437.60
10,382.90
Net Income After Extraordinaries
15,131.70
27,277.00
25,214.00
11,582.90
4,437.60
10,382.90
Net Income Available to Common
15,170.10
28,152.00
37,058.00
11,582.90
4,437.60
10,382.90
EPS (Basic)
4.50
6.00
4.17
0.15
0.06
0.04
Basic Shares Outstanding
3,007.70
4,928.80
8,877.90
75,357.00
68,272.00
234,162.20
EPS (Diluted)
5.04
5.35
4.17
0.15
0.06
0.04
Diluted Shares Outstanding
3,007.70
5,262.20
8,877.90
75,357.00
68,272.00
234,162.20
EBITDA
5,641.10
21,201.00
24,645.00
8,560.00
3,197.50
2,838.80
Non-Operating Interest Income
-
-
-
36.20
45.60
26.50
Preferred Dividends
38.40
875.00
11,844.00
-
-
-

About Amarantus BioScience Holdings

View Profile
Address
953 Indiana Street
San Francisco California 94104
United States
Employees -
Website http://www.amarantus.com
Updated 07/08/2019
Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.